Terms: = Skin cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Treatment
9 results:
1. Conditional Metastasis of Uveal Melanoma in 8091 Patients over Half-Century (51 Years) by Age Group: Assessing the Entire Population and the Extremes of Age.
Shields CL; Samuelson AG; Oh GJ; DeSimone JD; Sajjadi ZL; Bas Z; Kalafatis NE; Lally SE; Shields JA; Dockery PW
Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):7. PubMed ID: 37418273
[TBL] [Abstract] [Full Text] [Related]
2. Metastatic malignant melanoma mimicking a salivary gland basaloid neoplasm after treatment with nivolumab.
Lajara S; Landau M
Diagn Cytopathol; 2021 Sep; 49(9):E370-E373. PubMed ID: 34174024
[TBL] [Abstract] [Full Text] [Related]
3. Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line.
Yaman Ü; Aslan M; Ozturk S; Ulubayram K; Eroğlu İ
Pharm Dev Technol; 2020 Dec; 25(10):1192-1203. PubMed ID: 32729757
[TBL] [Abstract] [Full Text] [Related]
4. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Sahin U; Oehm P; Derhovanessian E; Jabulowsky RA; Vormehr M; Gold M; Maurus D; Schwarck-Kokarakis D; Kuhn AN; Omokoko T; Kranz LM; Diken M; Kreiter S; Haas H; Attig S; Rae R; Cuk K; Kemmer-Brück A; Breitkreuz A; Tolliver C; Caspar J; Quinkhardt J; Hebich L; Stein M; Hohberger A; Vogler I; Liebig I; Renken S; Sikorski J; Leierer M; Müller V; Mitzel-Rink H; Miederer M; Huber C; Grabbe S; Utikal J; Pinter A; Kaufmann R; Hassel JC; Loquai C; Türeci Ö
Nature; 2020 Sep; 585(7823):107-112. PubMed ID: 32728218
[TBL] [Abstract] [Full Text] [Related]
5. Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune response.
Ji W; Li L; Zhou S; Qiu L; Qian Z; Zhang H; Zhao P
J Drug Target; 2020 Nov; 28(9):982-990. PubMed ID: 32379004
[TBL] [Abstract] [Full Text] [Related]
6. Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma.
Grabbe S; Haas H; Diken M; Kranz LM; Langguth P; Sahin U
Nanomedicine (Lond); 2016 Oct; 11(20):2723-2734. PubMed ID: 27700619
[TBL] [Abstract] [Full Text] [Related]
7. Fibro-lipo-Lymph-Aspiration With a Lymph Vessel Sparing Procedure to Treat Advanced Lymphedema After Multiple Lymphatic-Venous Anastomoses: The Complete treatment Protocol.
Campisi CC; Ryan M; Boccardo F; Campisi C
Ann Plast Surg; 2017 Feb; 78(2):184-190. PubMed ID: 27404468
[TBL] [Abstract] [Full Text] [Related]
8. Pegylated liposomal doxorubicin (lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up.
; Chou HH; Wang KL; Chen CA; Wei LH; Lai CH; Hsieh CY; Yang YC; Twu NF; Chang TC; Yen MS
Gynecol Oncol; 2006 Jun; 101(3):423-8. PubMed ID: 16325239
[TBL] [Abstract] [Full Text] [Related]
9. A dose-escalating pilot study of sterically stabilized, pegylated liposomal doxorubicin (lipo-Dox) in patients with metastatic breast cancer.
Chao TC; Wang WS; Yen CC; Chiou TJ; Liu JH; Chen PM
Cancer Invest; 2003; 21(6):837-47. PubMed ID: 14735687
[TBL] [Abstract] [Full Text] [Related]
